In 2021, the Center for Drug Evaluation of the National Medical Products Administration (NMPA) in China received more than Investigational New Drug (IND) applications for innovative drugs. The application number grew substantially in the past few years, with the 2021 figure almost ** percent higher than the previous year. Almost all IND applications were concerning innovative chemical drugs or biopharmaceuticals, with only ** innovative Traditional Chinese Medicine (TCM) IND applications submitted in 2021.
An Investigational New Drug (IND) is a drug or biopharmaceutical product that is not yet approved for general use by the regulatory body while being used in clinical trials to examine its efficacy and safety. An IND application is the prerequisite for a drug product to enter its clinical trial phase.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
National Medical Products Administration. (March 18, 2025). Number of Investigational New Drug (IND) applications for innovative drugs submitted in China from 2018 to 2024, by drug type [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 06, 2026, from /statistics/1319951/china-number-of-investigationa-new-drug-applications-of-innovative-drugs-submitted/
National Medical Products Administration. "Number of Investigational New Drug (IND) applications for innovative drugs submitted in China from 2018 to 2024, by drug type." Chart. March 18, 2025. ÌÇÐÄÆƽâ°æ. Accessed August 06, 2026. /statistics/1319951/china-number-of-investigationa-new-drug-applications-of-innovative-drugs-submitted/
National Medical Products Administration. (2025). Number of Investigational New Drug (IND) applications for innovative drugs submitted in China from 2018 to 2024, by drug type. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 06, 2026. /statistics/1319951/china-number-of-investigationa-new-drug-applications-of-innovative-drugs-submitted/
National Medical Products Administration. "Number of Investigational New Drug (Ind) Applications for Innovative Drugs Submitted in China from 2018 to 2024, by Drug Type." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 18 Mar 2025, /statistics/1319951/china-number-of-investigationa-new-drug-applications-of-innovative-drugs-submitted/
National Medical Products Administration, Number of Investigational New Drug (IND) applications for innovative drugs submitted in China from 2018 to 2024, by drug type ÌÇÐÄÆƽâ°æ, /statistics/1319951/china-number-of-investigationa-new-drug-applications-of-innovative-drugs-submitted/ (last visited August 06, 2026)
Number of Investigational New Drug (IND) applications for innovative drugs submitted in China from 2018 to 2024, by drug type [Graph], National Medical Products Administration, March 18, 2025. [Online]. Available: /statistics/1319951/china-number-of-investigationa-new-drug-applications-of-innovative-drugs-submitted/
